Annual Cash & Cash Equivalents
$1.11 M
-$2.36 M-68.08%
June 30, 2024
Summary
- As of February 8, 2025, KZIA annual cash & cash equivalents is $1.11 million, with the most recent change of -$2.36 million (-68.08%) on June 30, 2024.
- During the last 3 years, KZIA annual cash & cash equivalents has fallen by -$19.62 million (-94.66%).
- KZIA annual cash & cash equivalents is now -97.26% below its all-time high of $40.47 million, reached on June 30, 2004.
Performance
KZIA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.11 M
-$1.32 M-54.37%
June 30, 2024
Summary
- As of February 8, 2025, KZIA quarterly cash and cash equivalents is $1.11 million, with the most recent change of -$1.32 million (-54.37%) on June 30, 2024.
- Over the past year, KZIA quarterly cash and cash equivalents has dropped by -$2.36 million (-68.08%).
- KZIA quarterly cash and cash equivalents is now -97.50% below its all-time high of $44.32 million, reached on December 31, 2007.
Performance
KZIA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KZIA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.1% | -68.1% |
| 3 y3 years | -94.7% | -68.1% |
| 5 y5 years | -70.9% | -68.1% |
KZIA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | at low | -89.9% | at low |
| 5 y | 5-year | -94.7% | at low | -92.6% | at low |
| alltime | all time | -97.3% | at low | -97.5% | +7.3% |
Kazia Therapeutics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | $1.11 M(-68.1%) | $1.11 M(-54.4%) |
| Dec 2023 | - | $2.43 M(-30.0%) |
| Jun 2023 | $3.47 M(-31.5%) | $3.47 M(+16.1%) |
| Dec 2022 | - | $2.99 M(-72.9%) |
| Jun 2022 | $5.06 M(-75.6%) | - |
| Dec 2021 | - | $11.01 M(-26.1%) |
| Jun 2021 | $20.73 M(+244.2%) | - |
| Dec 2020 | - | $14.89 M(+147.3%) |
| Jun 2020 | $6.02 M(+58.2%) | $6.02 M(+33.6%) |
| Dec 2019 | - | $4.51 M(+18.4%) |
| Jun 2019 | $3.81 M(-13.0%) | $3.81 M(-0.2%) |
| Dec 2018 | - | $3.81 M(-12.9%) |
| Jun 2018 | $4.38 M(-60.6%) | $4.38 M(-15.5%) |
| Dec 2017 | - | $5.18 M(-53.4%) |
| Jun 2017 | $11.11 M(-55.5%) | $11.11 M(-17.4%) |
| Dec 2016 | - | $13.45 M(-46.1%) |
| Jun 2016 | $24.98 M(-26.6%) | $24.98 M(-8.8%) |
| Dec 2015 | - | $27.40 M(-19.5%) |
| Jun 2015 | $34.03 M(+1344.8%) | $34.03 M(+418.1%) |
| Dec 2014 | - | $6.57 M(+178.8%) |
| Jun 2014 | $2.36 M(-7.3%) | $2.36 M(-56.4%) |
| Dec 2013 | - | $5.40 M(+112.7%) |
| Jun 2013 | $2.54 M | $2.54 M(+146.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $1.03 M(-87.7%) |
| Jun 2012 | $8.38 M(+35.9%) | $8.38 M(-33.5%) |
| Dec 2011 | - | $12.60 M(+104.5%) |
| Jun 2011 | $6.16 M(-41.5%) | $6.16 M(-33.3%) |
| Dec 2010 | - | $9.24 M(-12.2%) |
| Jun 2010 | $10.53 M(-53.1%) | $10.53 M(-42.1%) |
| Dec 2009 | - | $18.19 M(-19.0%) |
| Jun 2009 | $22.44 M(-16.3%) | $22.44 M(-27.7%) |
| Dec 2008 | - | $31.05 M(+15.8%) |
| Jun 2008 | $26.80 M(-20.1%) | $26.80 M(-39.5%) |
| Dec 2007 | - | $44.32 M(+32.2%) |
| Jun 2007 | $33.53 M(+34.7%) | $33.53 M(-8.3%) |
| Dec 2006 | - | $36.58 M(+47.0%) |
| Jun 2006 | $24.88 M(-30.6%) | $24.88 M(-20.1%) |
| Dec 2005 | - | $31.15 M(-13.1%) |
| Jun 2005 | $35.86 M(-11.4%) | $35.86 M(-4.5%) |
| Dec 2004 | - | $37.54 M(-7.2%) |
| Jun 2004 | $40.47 M(+94.6%) | $40.47 M(+94.6%) |
| Jun 2003 | $20.80 M(-7.5%) | $20.80 M(-7.5%) |
| Jun 2002 | $22.50 M(-27.7%) | $22.50 M(-27.7%) |
| Jun 2001 | $31.13 M(+81.1%) | $31.13 M(+81.1%) |
| Jun 2000 | $17.19 M(-12.7%) | $17.19 M |
| Jun 1999 | $19.70 M | - |
FAQ
- What is Kazia Therapeutics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kazia Therapeutics Limited?
- What is Kazia Therapeutics Limited annual cash & cash equivalents year-on-year change?
- What is Kazia Therapeutics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kazia Therapeutics Limited?
- What is Kazia Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
What is Kazia Therapeutics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of KZIA is $1.11 M
What is the all time high annual cash & cash equivalents for Kazia Therapeutics Limited?
Kazia Therapeutics Limited all-time high annual cash & cash equivalents is $40.47 M
What is Kazia Therapeutics Limited annual cash & cash equivalents year-on-year change?
Over the past year, KZIA annual cash & cash equivalents has changed by -$2.36 M (-68.08%)
What is Kazia Therapeutics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KZIA is $1.11 M
What is the all time high quarterly cash and cash equivalents for Kazia Therapeutics Limited?
Kazia Therapeutics Limited all-time high quarterly cash and cash equivalents is $44.32 M
What is Kazia Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, KZIA quarterly cash and cash equivalents has changed by -$2.36 M (-68.08%)